Life Science Matters An inside look at the latest legal developments involving medical devices, pharmaceuticals, and more

  • Home
  • About
  • Categories
    • ANDA
    • Class Action
    • Coronavirus
    • Daubert
    • Design Defect
    • FDA
    • IP
    • Labeling
    • Medical Device
    • News
    • Nutritional Supplements
    • Off Label
    • Pharmacy
    • Pharmaceuticals
    • Preemption
    • Recalls
    • Regulatory
    • Sales Representatives
    • Settlements
    • Supplements
    • Verdicts
  • Resources
  • Subscribe
  • Contact Us

This Week’s Life Science Headlines

  • November 7, 2013
  • /
  • FDA Medical Device News Pharmaceuticals Recalls Regulatory Settlements Verdicts
  • /
  • Life Science Matters
        Litigation
  • Pfizer Opposes Centralization of Lipitor Cases for Diabetic Women
  • J&J Settles Risperdal Lawsuit Over Illegal Marketing for $2.2B
  • High Court Won’t Hear Okla. Appeal Over Abortion-Drug Law (subscription required)
  • Supreme Court Asked to Take Up Lupron Labeling Suit (subscription required)
  • Granuflo Dialysate Lawsuits Conference to Discuss Pending Motions
  • Intuitive Surgical Insurance for da Vinci Robot Lawsuits Challenged
  • Pfizer Concealed Zoloft Ineffectiveness, Louisiana Lawsuit Claims
  • Topomaz Birth Defect Lawsuit Results in $4M Jury Award
  • Lipitor Diabetes Risk for Women was
…
Continue reading...
  • Abortion Drug Law ariad da Vinci robot drug shortages FDA black box warning granuflo dialysate inclusig internet enabled medical devices intuitive surgical insurance Johnson and Johnson Lipitor lipitor and diabetes lipitor diabetes risk for women lovenox lovenox paralysis lupron over-the-counter-drug recalls perrigo acetaminophen Pfizer potiga recall risperdal risperdal illegal marketing spinal bleeding topomaz topomaz birth defects tylenol and alochol zoloft
Goldberg Segalla

Search

Categories

  • Posts
  • Multicounty Litigation Order in New Jersey Provides No Guidance to Practitioners June 23, 2021
  • New Multicounty Litigation Application in New Jersey June 8, 2021
  • Lack of Agreement to Arbitrate Dooms Bid to Compel Arbitration May 26, 2021
  • Mixed Bag in New Jersey Medical Device Preemption Opinion May 12, 2021
  • First Circuit Agrees Pharmacists Provide Services, Not Sell Goods April 27, 2021

About Us

Goldberg Segalla is a national civil litigation firm with more than 20 offices in 10 states spanning major metro markets across the U.S., providing strategic coverage wherever our clients do business. As a firm of experienced litigators and trial attorneys, our capabilities span business and commercial disputes, employment and labor, insurance coverage, product liability, and more. Today, our nearly 400 attorneys are trusted counselors to public and private clients in key sectors and industries including construction and energy, transportation, manufacturing, retail and hospitality, and insurance.

Links

  • Home
  • About
  • Resources
  • Contact Us
Copyright 2022 · Goldberg Segalla